Coherentmarketinsightsus

  Immuno oncology assays includes the use of various immunology assays that are used to monitor the interaction between immune cells and cancer cells. The immune system of human body has a great potential to destroy tumor cells producing no toxicity to normal cells. Moreover, the immune system also has an ability to prevent recurrence of cancer. The Immuno Oncology Assays Market is segmented into research applications and clinical diagnostics based on application. In 2020, the research applications segment accounted for the largest share of the immuno-oncology assays market. The rising prominence of biomarker-based drug development is driving the growth of this segment. Immuno oncology assays are referred to as a next generation sequencing application. Immuno oncology assays helps in maintaining cell morphology along with cell health for real time measurements or continuous analysis. Immuno oncology assays market includes assays such as tumor killing assays, T cell...